A Oku Selected Research

Diabetes Complications

1/2001

Improved diabetic syndrome in C57BL/KsJ-db/db mice by oral administration of the Na(+)-glucose cotransporter inhibitor T-1095.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

A Oku Research Topics

Disease

6	Hyperglycemia 04/2002 - 03/2000
4	Insulin Resistance 05/2001 - 03/2000
2	Type 2 Diabetes Mellitus (MODY) 04/2002 - 01/2001
2	Body Weight (Weight, Body) 01/2001 - 11/2000
2	Diabetes Mellitus 12/2000 - 11/2000
1	Glucose Intolerance 01/2001
1	Albuminuria 01/2001
1	Diabetic Nephropathies (Diabetic Nephropathy) 01/2001
1	Diabetes Complications 01/2001
1	Glycosuria 12/2000
1	Hypoglycemia (Reactive Hypoglycemia) 12/2000
1	Neoplasms (Cancer) 02/2000

Drug/Important Bio-Agent (IBA)

8	T 1095IBA 04/2002 - 03/2000
5	Glucose (Dextrose)FDA LinkGeneric 04/2002 - 03/2000
4	Insulin (Novolin)FDA Link 04/2002 - 03/2000
4	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 05/2001 - 03/2000
3	Streptozocin (Streptozotocin)FDA Link 05/2001 - 08/2000
2	benzofuranIBA 01/2001 - 11/2000
2	Blood Glucose (Blood Sugar)IBA 01/2001 - 11/2000
1	Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA 05/2001
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 05/2001
1	Therapeutic UsesIBA 01/2001
1	PhlorhizinIBA 01/2001
1	Hypoglycemic Agents (Hypoglycemics)IBA 12/2000
1	KetonesIBA 03/2000
1	Nonesterified Fatty Acids (NEFA)IBA 03/2000
1	SodiumIBA 03/2000
1	GurIBA 03/2000
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 02/2000

Therapy/Procedure

1	Oral Administration 12/2000